Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of pharmaceutical
compound (API 31510) topical cream topically applied to superficial basal cell carcinomas to
obtain preliminary efficacy data for the treatment of superficial basal cell carcinomas by
API 31510 topical cream. The study population will include one hundred and sixty (160)
otherwise healthy male or female adults with one or more histologically confirmed superficial
basal cell carcinoma lesions. One target lesion with an area of less than one inch will be
designated for study treatment.